India will receive 60-70 million doses of the Covishield vaccine from Oxford by December, but the vaccines will hit the market in March 2021, the Serum Institute of India (SII) in Pune said, revealing its latest updates on the ongoing trial of the Astrazeneca-Oxford vaccine. Time between December and March …
Read More »
After rejecting the first proposal, India’s General Drug Controller finally allowed Dr. Reddy’s to conduct a phase 2/3 human clinical trial of Sputnik V, the Covid-19 vaccine that makes Russia the first country in develop a vaccine. “This will be a multicentre, randomized controlled study, including a safety and immunogenicity …
Read More »
Prime Minister Narendra Modi held a review meeting on Thursday to assess the progress of research and the vaccine development ecosystem to combat Covid-19. Be it tests, vaccines and drugs, the solution has to be cost-effective, readily available and scalable, the Prime Minister said. The meeting was attended by Union …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: September 11, 2020 7:29:25 am Covid-19 testing in New Delhi. IBS Sponsors Mid- and Late-Stage Human Clinical Trials for Candidate Vaccine in India Serum Institute of India has decided to stop the ongoing clinical trials in India of the Covid-19 candidate …
Read More »